April 25, 2019
Rainier Therapeutics Announces Vofatamab Data Accepted for Presentation at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
-FIERCE-21 and FIERCE-22 Phase 2 Trials in Metastatic Bladder Cancer- SAN LEANDRO, Calif.–(BUSINESS WIRE)–Rainier Therapeutics, Inc., a privately-held clinical stage…